NCT00000236View on ClinicalTrials.gov

Buprenorphine Pharmacology Related to Addiction Treatment - 18

PHASE2CompletedINTERVENTIONAL
0
Timeline

Start Date

Not specified

Conditions
Opioid-Related Disorders
Interventions
DRUG

Buprenorphine/naloxone

Trial Locations (1)

05401

Treatment Research Center, Burlington

All Listed Sponsors
collaborator

University of Vermont

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00000236 - Buprenorphine Pharmacology Related to Addiction Treatment - 18 | Biotech Hunter | Biotech Hunter